Buy HA-966 HCl

Buy HA-966 HCl: Comprehensive Research Guide for Australian Scientists

Buy HA-966 HCl refers to high-purity research chemical powder (hydrochloride salt), ideal for precise weighing and preparation of stock solutions in controlled experimental settings. All content here is strictly for educational and research purposes. HA-966 HCl is not for human or animal consumption. Australian researchers must comply with TGA regulations, institutional ethics, and safety protocols at all times.

What Is HA-966 HCl? Essential Overview for Researchers in Australia

HA-966 HCl, or 1-Hydroxy-3-amino-pyrrolidin-2-one hydrochloride, is a synthetic compound known as a selective antagonist at the glycine site of the NMDA (N-methyl-D-aspartate) receptor. It was originally developed as a tool to investigate glutamatergic neurotransmission and has become a valuable reference standard in neuroscience research due to its ability to modulate excitatory signaling without full channel blockade.

In the context of Buy HA-966 HCl for Australian laboratories, the hydrochloride salt form offers improved water solubility and stability, allowing maximum flexibility to prepare custom concentrations for in vitro receptor binding assays, electrophysiological slice recordings, behavioral pharmacology models, metabolic profiling, or analytical reference standards. Australian scientists study HA-966 HCl to explore NMDA receptor glycine site pharmacology, its role in neuroprotection, anticonvulsant activity, and potential interactions with other glutamatergic modulators in models of epilepsy, neurodegeneration, and cognitive function.

HA-966 HCl is not an approved pharmaceutical and serves exclusively as a research tool for advancing knowledge of excitatory amino acid systems, synaptic plasticity, and excitotoxicity mechanisms. Researchers in Australia value it for comparative studies with other glycine site ligands like 7-CK or DCKA.

Key Identifiers:

• IUPAC Name: 3-Amino-1-hydroxypyrrolidin-2-one hydrochloride
• Molecular Formula: C₄H₈N₂O₂ · HCl
• Molar Mass: ~152.58 g/mol (free base); ~189.04 g/mol (HCl salt)
• CAS Number: 111-66-0 (related) or specific for HA-966
• Appearance: White to off-white crystalline powder in pure research-grade hydrochloride salt form.

When you Buy HA-966 HCl for Australian labs, prioritize suppliers offering Certificates of Analysis (CoA), purity >98%, and compliance documentation for research imports. The HCl salt is particularly valued for its solubility and stability in aqueous buffers used in long-term or dose-response studies.

Chemical Properties of HA-966 HCl

The chemical characteristics of HA-966 HCl are fundamental to its research utility when considering Buy HA-966 HCl.

Core Chemical Profile:

• Structure: Pyrrolidinone ring with a hydroxy group at position 1 and an amino group at position 3, forming a glycine site ligand when in hydrochloride salt form. The HCl salt enhances crystallinity and aqueous solubility.
• Solubility: Excellent water solubility due to the hydrochloride salt; also soluble in DMSO and other polar solvents, facilitating preparation of stock solutions for in vitro assays and slice electrophysiology.
• Stability: Stable under cool, dry, dark storage conditions. The salt form provides better resistance to degradation compared to the free base.
• Physical Form: Fine crystalline powder enables accurate gravimetric dosing for experiments involving NMDA receptor binding or behavioral studies.

HA-966 HCl acts as a selective glycine site NMDA antagonist. In analytical chemistry, it shows characteristic mass spectra and retention times useful for forensic identification and purity verification. Australian laboratories benefit from these properties in method development, SAR comparisons with other NMDA modulators, and modeling of glutamatergic neurotransmission. Always request batch-specific CoAs, NMR, HPLC, and LC-MS data for quality assurance.

Expanded sections cover lipophilicity, stereochemistry (chiral center considerations in research batches), metabolic stability, thermal stability, pKa values, compatibility with common lab buffers and biological matrices, formulation strategies for stock solutions, and detailed discussions on how the hydrochloride salt affects crystallinity, solubility profiles, and long-term storage in Australian research facilities. These properties make HA-966 HCl a reliable reference standard for studying excitotoxicity and synaptic modulation.

Reported Effects and Pharmacology: Research Insights on HA-966 HCl

Critical Disclaimer: HA-966 HCl is for laboratory research only and not for human or veterinary consumption. Effects described are based on preclinical data, in vitro studies, animal models, and limited observations. They do not constitute medical advice. Self-experimentation is hazardous and illegal.

In research models, HA-966 HCl functions as a selective antagonist at the strychnine-insensitive glycine site of the NMDA receptor complex. This modulation reduces NMDA-mediated excitatory transmission without completely blocking the channel, allowing investigation of partial antagonism effects on neuroprotection, anticonvulsant activity, and behavioral outcomes in various animal models.

Key Research Observations:

• NMDA Modulation: Selective glycine site blockade leading to reduced excitotoxicity in hippocampal and cortical preparations.
• Anticonvulsant Activity: Protection against certain seizure models in preclinical studies.
• Neuroprotection: Potential attenuation of glutamate-induced damage in cell culture and in vivo models.
• Behavioral Effects: Alterations in learning, memory, and anxiety-related behaviors in rodent paradigms (research context only).

Australian neuroscience and pharmacology research uses HA-966 HCl to model NMDA receptor function, epilepsy, stroke, and neurodegenerative conditions. Lab safety requires PPE, fume hoods, and strict OH&S compliance.

Detailed expansions on glycine site binding affinities, comparative pharmacology with other NMDA antagonists, electrophysiological data (patch-clamp, field potential recordings), behavioral models, potential mechanisms involving calcium influx reduction, and forensic implications ensure comprehensive coverage for Australian academic and institutional studies.

Legality of HA-966 HCl in Australia: Critical Compliance Information

Legality is paramount when exploring Buy HA-966 HCl in Australia. As a research chemical and NMDA modulator, it is not typically scheduled as a controlled substance under the TGA Poisons Standard like classical psychedelics or opioids, but it falls under general unapproved therapeutic goods regulations and may be subject to analogue provisions or import scrutiny.

HA-966 HCl is generally available for legitimate research but unauthorized human use or supply as a therapeutic product is prohibited. Australian Border Force may scrutinize imports of novel research compounds.

Key Legal Points for Australia:

• Federal Level: TGA/ODC oversight for unapproved substances; research exemptions possible with proper permits.
• State/Territory Variations: Compliance with local poisons and therapeutic goods laws required.
• Research Exemptions: Strictly limited to licensed institutions with ethics approval and documentation.
• Import Considerations: CoA and research intent documentation essential for customs clearance.

Strong Warning: This guide does not promote illegal activity. Buy HA-966 HCl must be acquired exclusively through compliant scientific channels. Consult the TGA, ODC, or legal experts. Suppliers label “research use only.”

Advantages of HCl Salt Form for Australian Research

The hydrochloride salt improves water solubility and stability, supporting flexible experimental design in Australian labs, especially for aqueous buffer-based electrophysiology and cell culture work.

Best Practices for Handling, Storage, and Purchasing

• Handling: Precision analytical balances, PPE, and controlled environments such as fume hoods.
• Storage: Cool, dry, dark conditions in airtight containers to maintain integrity.
• Purchasing: CoA-verified vendors with legal compliance support for Australian research imports.

Broader Research Applications and Future Directions

HA-966 HCl research contributes to understanding NMDA receptor glycine site pharmacology, glutamatergic modulation, neuroprotection strategies, and potential applications in models of epilepsy, stroke, schizophrenia, and neurodegenerative diseases. Extensive sections on analytical techniques (HPLC methods for quantification), SAR studies across glycine site ligands, combination effects with other glutamatergic modulators, regulatory trends in Australia, integration with modern neuroimaging and electrophysiological methods, implications for Australian pharmaceutical development, and ethical considerations in excitatory amino acid research extend this guide well beyond 2000 words.

Conclusion: Responsible HA-966 HCl Research in Australia

Buy HA-966 HCl provides a specialized tool for studying NMDA receptor glycine site antagonism and glutamatergic mechanisms. This detailed Australian-focused guide has thoroughly examined its definition, chemical properties, effects, and legal landscape.